Endogenous Glucagon-like Peptide-1 Suppresses High-Fat Food Intake by Reducing Synaptic Drive onto Mesolimbic Dopamine Neurons
Glucagon-like peptide-1 (GLP-1) and its analogs act as appetite suppressants and have been proven to be clinically efficacious in reducing body weight in obese individuals. Central GLP-1 is expressed in a small population of brainstem cells located in the nucleus tractus solitarius (NTS), which proj...
Main Authors: | Xue-Feng Wang, Jing-Jing Liu, Julia Xia, Ji Liu, Vincent Mirabella, Zhiping P. Pang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-08-01
|
Series: | Cell Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124715006889 |
Similar Items
-
Proceedings: Amphetamine and apomorphine responses in the rat after lesion of mesolimbic or striatal dopamine neurones.
by: Iversen, S, et al.
Published: (1975) -
GABAergic Control of Nigrostriatal and Mesolimbic Dopamine in the Rat Brain
by: Susanne Nikolaus, et al.
Published: (2018-03-01) -
Dissociable cost and benefit encoding of future rewards by mesolimbic dopamine.
by: Gan, J, et al.
Published: (2010) -
Action initiation shapes mesolimbic dopamine encoding of future rewards
by: Syed, ECJ, et al.
Published: (2016) -
Mesolimbic dopamine and circuit level mechanisms in action initiation and restraint
by: Jenkins, G
Published: (2023)